“The knowledge that DPH has the property of reducing CMRO2, the lactates production and of increasing the cerebral level of glucose , glycogen and phosphocreatinine, has persuaded us to use this drug instead of barbiturate, as a therapeutic protection to prevent hypoxic damages to the nervous cell.”